{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:00:58Z","timestamp":1790877658731,"version":"4.1.0"},"update-to":[{"DOI":"10.1016\/j.cca.2024.119704","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cca.2024.119704","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T04:36:05Z","timestamp":1714451765000},"page":"119704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["RETRACTED: Very unusual extremely high ferritin with cytokine release syndrome in a patient with hematological malignancy after experimental chimeric antigen receptor (CAR)\u2013T-Cell therapy"],"prefix":"10.1016","volume":"559","author":[{"given":"Robert","family":"Hoyt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2024.119704_b0005","doi-asserted-by":"crossref","first-page":"5474602","DOI":"10.1155\/2016\/5474602","article-title":"CAR T cell therapy: a game changer in cancer treatment","volume":"2016","author":"Almasbak","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cca.2024.119704_b0010","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1002\/cam4.5551","article-title":"Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies","volume":"12","author":"Abbasi","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.cca.2024.119704_b0015","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41587-023-01981-8","article-title":"Expanding access to CAR T cell therapies through local manufacturing","volume":"41","author":"Elsallab","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cca.2024.119704_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11899-023-00687-7","article-title":"CAR-T cell therapy: the efficacy and toxicity balance","volume":"18","author":"Chohan","year":"2023","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"14","key":"10.1016\/j.cca.2024.119704_b0025","article-title":"A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed\/refractory multiple myeloma patients treated with CAR-T cells","volume":"19","author":"Liu","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.cca.2024.119704_b0030","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3390\/jcm10092008","article-title":"Hyperferritinemia\u2014a clinical overview","volume":"10","author":"Sandnes","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2024.119704_b0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ajcp\/aqw053","article-title":"Extreme hyperferritinemia: causes and impact on diagnostic reasoning","volume":"145","author":"Sackett","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cca.2024.119704_b0040","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.3390\/jcm11185438","volume":"11","author":"Fauter","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2024.119704_b0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.cca.2024.119704_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy \u2014 assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cca.2024.119704_b0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.cca.2024.119704_b0060","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/CCM.0000000000002053","article-title":"Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia","volume":"45","author":"Fitzgerald","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2024.119704_b0065","first-page":"2430","article-title":"How I treat refractory CRS and ICANS after CAR T-cell therapy?","volume":"141","author":"Jain","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.cca.2024.119704_b0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PCC.0000000000001029","article-title":"A systemic inflammation mortality risk assessment contingency table for severe sepsis","volume":"18","author":"Carcillo","year":"2016","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.cca.2024.119704_b0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.11613\/BM.2016.029","article-title":"Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis","volume":"26","author":"Denimal","year":"2016","journal-title":"Biochem Med (zagreb)."},{"key":"10.1016\/j.cca.2024.119704_b0080","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood-2018-12-893396","article-title":"Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells","volume":"133","author":"Karschnia","year":"2019","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.cca.2024.119704","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124019454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124019454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:17:59Z","timestamp":1790875079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124019454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":16,"alternative-id":["S0009898124019454"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119704","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Very unusual extremely high ferritin with cytokine release syndrome in a patient with hematological malignancy after experimental chimeric antigen receptor (CAR)\u2013T-Cell therapy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119704"}}